What is the average analyst recommendation for Kenvue?
The average recommendation is "Hold."
Yanuki
ARTICLE DETAIL
Kenvue (KVUE) Stock: Analyst Ratings, Congressional Trades, and Performance | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Kenvue (KVUE) Stock: Analyst Ratings, Congressional Trades, and Performance | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026
Finance / Stocks
Kenvue (KVUE) Stock: Analyst Ratings, Congressional Trades, and Performance
Kenvue Inc. (KVUE) has been the subject of recent attention from analysts and investors alike. This article summarizes key developments, including analyst ratings, congressional trades, dividend announcements, and stock performance.
Key Insights
- Senator Sheldon Whitehouse sold between $1,001 and $15,000 of Kenvue Inc. (NYSE:KVUE) stock on August 28.
- Kenvue reported $3.84 billion in revenue for its last quarter, slightly below analysts' expectations, while earnings per share came in at $0.29, beating estimates.
- The company declared a quarterly dividend of $0.2075 per share, representing an annualized dividend of $0.83 with a yield of 4.0%.
- Thirteen analysts have provided ratings for Kenvue, with an average recommendation of "Hold" and an average 12-month target price of $24.38.
In-Depth Analysis
Kenvue Inc. (NYSE:KVUE) operates as a consumer health company with segments in Self Care, Skin Health and Beauty, and Essential Health. Recent analysis reveals the following:
**Analyst Ratings:** Kenvue has received an average recommendation of "Hold" from analysts. Brokerages like UBS Group, JPMorgan Chase & Co., Citigroup, and Canaccord Genuity Group have adjusted their price targets, reflecting varied expectations for the stock's future performance.
**Dividend Information:** Kenvue recently declared a quarterly dividend of $0.2075 per share, equating to an annualized dividend of $0.83 and a dividend yield of 4.0%. The dividend was paid on Wednesday, August 27th, to stockholders of record on Wednesday, August 13th.
**Stock Performance:** On Monday, KVUE traded down $0.21, hitting $20.33. The stock has a 12-month low of $19.75 and a 12-month high of $25.17. The company’s market capitalization is $39.02 billion, with a P/E ratio of 27.21.
**Institutional Ownership:** Hedge funds and institutional investors hold a significant portion of Kenvue's stock. Vanguard Group Inc. and Geode Capital Management LLC have increased their positions, indicating confidence in the company's long-term prospects.
FAQ
What was Kenvue's revenue for the last quarter?
Kenvue reported $3.84 billion in revenue.
What is Kenvue's annual dividend?
The annualized dividend is $0.83 per share.
Takeaways
- Monitor analyst ratings for changing sentiments.
- Track dividend announcements for income opportunities.
- Observe institutional investment trends to gauge long-term confidence.
Discussion
What are your thoughts on Kenvue's future performance? Do you think the analyst ratings accurately reflect the company's potential? Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.